{"url":"https://lda.senate.gov/api/v1/filings/9c82a2e9-5ed7-4d9e-abbb-82b984c8a910/","filing_uuid":"9c82a2e9-5ed7-4d9e-abbb-82b984c8a910","filing_type":"RA","filing_type_display":"Registration - Amendment","filing_year":2008,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/9c82a2e9-5ed7-4d9e-abbb-82b984c8a910/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"J. Richard Jorden","dt_posted":"2008-10-20T12:14:48-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"27780 NOVI ROAD, SUITE 200","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"NOVI","registrant_state":"MI","registrant_zip":"48377","registrant":{"id":84332,"url":"https://lda.senate.gov/api/v1/registrants/84332/","house_registrant_id":36474,"name":"STRATEGIC FEDERAL AFFAIRS","description":"Community College","address_1":"9864 E. Grand River Ave.","address_2":"Ste. 110-299","address_3":null,"address_4":null,"city":"Brighton","state":"MI","state_display":"Michigan","zip":"48116","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MELENA CUMMINGS","contact_telephone":"+1 734-474-0019","dt_updated":"2023-07-06T17:25:14.950888-04:00"},"client":{"id":172342,"url":"https://lda.senate.gov/api/v1/clients/172342/","client_id":797,"name":"INTERMEDIARY BIOCHEMICALS","general_description":"Medical and science technology, research and development","client_government_entity":false,"client_self_select":false,"state":"MI","state_display":"Michigan","country":"US","country_display":"United States of America","ppb_state":"MI","ppb_state_display":"Michigan","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-09-30"},"lobbying_activities":[{"general_issue_code":"ENG","general_issue_code_display":"Energy/Nuclear","description":"Medical and science technology, Energy research and development related appropriations","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":1714,"prefix":"mr","prefix_display":"MR.","first_name":"ROBERT","nickname":null,"middle_name":"C","last_name":"LAW","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":41011,"prefix":"mr","prefix_display":"MR.","first_name":"CHARLES","nickname":null,"middle_name":"G","last_name":"YESSAIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":44679,"prefix":"ms","prefix_display":"MS.","first_name":"LISA","nickname":null,"middle_name":"A","last_name":"NOCERINI","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}